Skip to main content
GutCited

Lactobacillus rhamnosus GG untuk Irritable Bowel Syndrome (IBS)

B Bukti Setidaknya satu uji coba acak mendukung hal ini, dengan hasil yang sebagian besar konsisten.

Several RCTs show improvement in IBS symptoms, particularly bloating and abdominal pain. Effect strongest in IBS-D subtype. Results not uniform across all IBS subtypes.

B

Kesimpulan

Several RCTs show improvement in IBS symptoms, particularly bloating and abdominal pain. Effect strongest in IBS-D subtype. Results not uniform across all IBS subtypes.

Key Study Findings

Systematic Review
Probiotics for Irritable Bowel Syndrome: Clinical Data in Children.
Dose: various probiotic strains vs: placebo Outcome: IBS symptom improvement in children Efek: LGG showed benefit in some studies

Populasi: Children with IBS

Randomized Controlled Trial 24 weeks Double-blind
Clinical studies on alleviating the symptoms of irritable bowel syndrome.
Dose: Probiotic combination (LGG + 3 strains) daily vs: Placebo Outcome: IBS total symptom score reduction Efek: 42% reduction vs 6% placebo

Populasi: IBS patients

Randomized Controlled Trial n=103 24 weeks Double-blind
A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
Dose: Probiotic capsule daily (LGG, LC705, Bb99, JS) vs: Placebo capsule Outcome: IBS total symptom score Efek: -7.7 points (95% CI: -13.9 to -1.6); 42% vs 6% 0.015

Populasi: IBS patients meeting Rome I or II criteria

Key Statistics

8

Studi

1.200

Peserta

↑

Positive

B

Peringkat

Referenced Papers

Digestive diseases (Basel, … 2016 37 sitasi
Journal of pediatric … 2016 19 sitasi
Asia Pacific journal … 2006 45 sitasi

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosis yang Umum Digunakan

General:
10-20 billion CFU/day
Ibs Support:
10 billion CFU/day for 4-8 weeks
Aad Prevention:
10-20 billion CFU/day (start with antibiotic, continue 7 days after)

Batas atas: Generally well-tolerated up to 40 billion CFU/day in clinical trials

Dosis yang Diteliti dalam Penelitian

Dosis Durasi Efek N
various probiotic strains -- Mixed --
Probiotic combination (LGG + 3 strains) daily 24 weeks Positive --
Probiotic capsule daily (LGG, LC705, Bb99, JS) 24 weeks Positive 103

Waktu terbaik diminum: On an empty stomach or 30 minutes before meals for optimal survival

Safety & Side Effects

Efek Samping yang Dilaporkan

  • ⚠ Mild gas and bloating during initial use (usually resolves in 1-2 weeks)
  • ⚠ Rare reports of bacteremia in severely immunocompromised individuals
  • ⚠ Occasional loose stools during adjustment period
  • ⚠ Very rare: systemic infection in critically ill patients with central venous catheters

Interaksi yang Diketahui

  • ● Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
  • ● Immunosuppressants (theoretical risk of infection in immunocompromised patients)
  • ● Antifungals (no known interaction but may affect gut flora balance)

Asupan atas yang dapat ditoleransi: Generally well-tolerated up to 40 billion CFU/day in clinical trials

Selalu konsultasikan dengan tenaga kesehatan Anda sebelum memulai suplemen apa pun.Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai suplemen apa pun.

Frequently Asked Questions

Does Lactobacillus rhamnosus GG help with Irritable Bowel Syndrome (IBS)?
Based on 8 studies with 1,200 participants, there is moderate evidence from clinical studies that Lactobacillus rhamnosus GG may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Lactobacillus rhamnosus GG should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 10-20 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Lactobacillus rhamnosus GG?
Reported side effects may include Mild gas and bloating during initial use (usually resolves in 1-2 weeks), Rare reports of bacteremia in severely immunocompromised individuals, Occasional loose stools during adjustment period, Very rare: systemic infection in critically ill patients with central venous catheters. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Lactobacillus rhamnosus GG and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 8 peer-reviewed studies with 1,200 total participants. The overall direction of effect is positive.

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

References

  1. [1] Roman Maslennikov et al.. J Clin Med. 2026. Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome. doi:10.3390/jcm15031152 PubMed
  2. [2] Silvia Salvatore et al.. Nutrients. 2024. Nutraceuticals and Pain Disorders of the Gut-Brain Interaction in Infants and Children: A Narrative Review and Practical Insights. doi:10.3390/nu16030349 PubMed
  3. [3] Carrie A M Wegh et al.. J Clin Gastroenterol. 2018. Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review. doi:10.1097/MCG.0000000000001054 PubMed
  4. [4] Hania Szajewska et al.. Dig Dis. 2016. Probiotic Bacterial and Fungal Strains: Claims with Evidence. doi:10.1159/000443359 PubMed
  5. [5] Eleonora Giannetti et al.. J Pediatr Gastroenterol Nutr. 2016. Probiotics for Irritable Bowel Syndrome: Clinical Data in Children. doi:10.1097/MPG.0000000000001220 PubMed
  6. [6] Sylvia Cruchet et al.. Paediatr Drugs. 2015. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. doi:10.1007/s40272-015-0124-6 PubMed
  7. [7] Danielle Barnes et al.. Nutr Clin Pract. 2015. Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children. doi:10.1177/0884533615610081 PubMed
  8. [8] Anna Lyra et al.. BMC Gastroenterol. 2010. Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. doi:10.1186/1471-230X-10-110 PubMed
  9. [9] K Kajander et al.. Aliment Pharmacol Ther. 2007. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. doi:10.1111/j.1365-2036.2007.03391.x PubMed
  10. [10] Seppo Salminen et al.. Asia Pac J Clin Nutr. 2006. Intestinal colonisation, microbiota and future probiotics? PubMed
  11. [11] Kajsa Kajander et al.. Asia Pac J Clin Nutr. 2006. Clinical studies on alleviating the symptoms of irritable bowel syndrome. PubMed
  12. [12] K Kajander et al.. Aliment Pharmacol Ther. 2005. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. doi:10.1111/j.1365-2036.2005.02579.x PubMed

Penafian FDA: Pernyataan-pernyataan ini belum dievaluasi oleh Food and Drug Administration. Produk dan informasi di situs web ini tidak dimaksudkan untuk mendiagnosis, mengobati, menyembuhkan, atau mencegah penyakit apa pun. Peringkat bukti yang disajikan didasarkan pada analisis kami terhadap penelitian yang ditinjau sejawat dan tidak merupakan saran medis. Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai regimen suplemen apa pun.